[go: up one dir, main page]

BRPI0814555A2 - O uso de compostos à base de lantibiótico com atividade antimicrobiana - Google Patents

O uso de compostos à base de lantibiótico com atividade antimicrobiana

Info

Publication number
BRPI0814555A2
BRPI0814555A2 BRPI0814555-5A2A BRPI0814555A BRPI0814555A2 BR PI0814555 A2 BRPI0814555 A2 BR PI0814555A2 BR PI0814555 A BRPI0814555 A BR PI0814555A BR PI0814555 A2 BRPI0814555 A2 BR PI0814555A2
Authority
BR
Brazil
Prior art keywords
antimicrobian
activity
lantibiotic compounds
lantibiotic
compounds
Prior art date
Application number
BRPI0814555-5A2A
Other languages
English (en)
Inventor
Sjoerd Nicolaas Wadman
Original Assignee
Novacta Biosystems Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novacta Biosystems Ltd filed Critical Novacta Biosystems Ltd
Publication of BRPI0814555A2 publication Critical patent/BRPI0814555A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/365—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinoplanes (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0814555-5A2A 2007-07-18 2008-07-18 O uso de compostos à base de lantibiótico com atividade antimicrobiana BRPI0814555A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0714029.6A GB0714029D0 (en) 2007-07-18 2007-07-18 Lantibiotic-based compounds having antimicrobial activity
PCT/GB2008/002465 WO2009010765A2 (en) 2007-07-18 2008-07-18 Lantibiotic-based compounds having antimicrobial activity

Publications (1)

Publication Number Publication Date
BRPI0814555A2 true BRPI0814555A2 (pt) 2015-01-06

Family

ID=38476566

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0814555-5A2A BRPI0814555A2 (pt) 2007-07-18 2008-07-18 O uso de compostos à base de lantibiótico com atividade antimicrobiana

Country Status (13)

Country Link
US (1) US8329644B2 (pt)
EP (1) EP2167527A2 (pt)
JP (1) JP5389023B2 (pt)
KR (1) KR20100044849A (pt)
CN (1) CN101796067A (pt)
AU (1) AU2008277422A1 (pt)
BR (1) BRPI0814555A2 (pt)
CA (1) CA2693051A1 (pt)
EA (1) EA018841B1 (pt)
GB (1) GB0714029D0 (pt)
IL (1) IL202620A0 (pt)
NZ (1) NZ581885A (pt)
WO (1) WO2009010765A2 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0600928D0 (en) 2006-01-17 2006-02-22 Novacta Biosystems Ltd Improvements relating to lantibiotics
GB0714030D0 (en) * 2007-07-18 2007-08-29 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity
GB0714029D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd Lantibiotic-based compounds having antimicrobial activity
NZ594011A (en) 2009-01-14 2013-12-20 Novacta Biosystems Ltd Deoxyactagardine derivatives
GB0900599D0 (en) * 2009-01-14 2009-02-18 Novacta Biosystems Ltd Treatment
TWI504610B (zh) 2009-02-04 2015-10-21 Novacta Biosystems Ltd 阿肽加定衍生物、其製備方法及其用途
GB201001688D0 (en) * 2010-02-02 2010-03-17 Novacta Biosystems Ltd Compounds
CA2789164A1 (en) * 2010-02-02 2011-08-11 Novacta Biosystems Limited Lantibiotic salts
JP2013531026A (ja) * 2010-07-14 2013-08-01 ノヴァクタ バイオシステムズ リミティッド Ｂ型ランチビオティックを含む製剤
GB201013509D0 (en) * 2010-08-11 2010-09-22 Novacta Biosystems Ltd Compounds
GB201013507D0 (en) * 2010-08-11 2010-09-22 Novacta Biosystems Ltd Compounds
GB201013513D0 (en) * 2010-08-11 2010-09-22 Novacta Biosystems Ltd Formulations
GB201013508D0 (en) * 2010-08-11 2010-09-22 Novacta Biosystems Ltd Compounds
WO2012135636A1 (en) * 2011-03-30 2012-10-04 Sentinella Pharmaceuticals, Inc. Lantibiotic nai-802, pharmaceutically acceptable salts, compositions, and uses thereof
GB201213434D0 (en) * 2012-07-27 2012-09-12 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity
WO2014085637A1 (en) * 2012-11-30 2014-06-05 Sentinella Pharmaceuticals, Inc. New lantibiotic derivatives and a process for their preparation
WO2014193237A2 (en) * 2013-05-30 2014-12-04 Academisch Ziekenhuis Leiden H.O.D.N. Lumc C diff protease

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3710795A (en) * 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
GB8507528D0 (en) 1985-03-22 1985-05-01 Lepetit Spa Basis monocarboxyamide derivatives
US5304540A (en) 1988-06-22 1994-04-19 Applied Microbiology, Inc. Pharmaceutical bacteriocin compositions and methods for using the same
IN167138B (pt) * 1988-08-17 1990-09-01 Hoechst India
GB8926639D0 (en) 1989-11-24 1990-01-17 Agricultural & Food Res Delayed release formulations
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
IT1260505B (it) 1992-06-01 1996-04-09 Poli Ind Chimica Spa Sistemi farmaceutici orali a cessione ritardata per il rilascio specifico nel colon
IL107887A (en) * 1992-12-08 2003-07-06 Ambi Inc Stabilized lanthionine containing bacteriocin compositions
US5512269A (en) 1993-06-09 1996-04-30 Burroughs Wellcome, Co. Method of treating retained pulmonary secretions
ATE255165T1 (de) 1994-09-12 2003-12-15 Aventis Pharma Gmbh Rekombinantes mersacidin und verfahren zu seiner herstellung
AU713050B2 (en) 1995-06-23 1999-11-25 Ambi Inc. A method for the control of antibiotic-resistant gram positive bacteria and treatment of infection
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
US5958873A (en) 1997-06-09 1999-09-28 University Of Cincinnati Oral formulation for treatment of bacteria-induced diseases of the colon
US5985823A (en) * 1997-06-09 1999-11-16 Ambi Inc. Method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
DE19745583A1 (de) * 1997-10-15 1999-04-22 Hoechst Marion Roussel De Gmbh Neues Lantibiotikum verwandt mit Actagardine, Verfahren zur Herstellung und Verwendung derselben
US6569830B1 (en) * 1999-03-05 2003-05-27 Ambi, Inc. Compositions and methods for treatment of staphylococcal infection while suppressing formation of antibiotic-resistant strains
NZ522783A (en) 2000-06-28 2004-07-30 Smithkline Beecham P Wet milling process for pharmaceuticals with agitator or chamber having nylon with internal lubricant
GB0110432D0 (en) 2001-04-27 2001-06-20 Plant Bioscience Ltd Lantibiotic production
WO2002103010A1 (en) 2001-06-14 2002-12-27 Plant Bioscience Limited Methods and materials for targeted gene disruption in actinomycete bacteria
US6861236B2 (en) 2002-05-24 2005-03-01 Applied Nanosystems B.V. Export and modification of (poly)peptides in the lantibiotic way
AU2003275129A1 (en) 2002-10-10 2004-05-04 Molichem Medicines, Inc. Nucleic acids encoding duramycin
US7351687B2 (en) 2003-07-18 2008-04-01 Vicuron Pharmaceuticals, Inc. Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof
JP4163737B2 (ja) 2003-07-18 2008-10-08 ヴァイキュロン ファーマシューティカルズ， インコーポレイテッド 抗生物質１０７８９１、そのａ１因子とａ２因子、その薬剤学的に許容される塩、組成物、およびその使用
GB0406870D0 (en) 2004-03-26 2004-04-28 Novacta Biosystems Ltd Improvements relating to the production of lantibiotics
JP2009509519A (ja) 2005-09-27 2009-03-12 ノヴァクタ バイオシステムズ リミティッド ランチビオティックメルサシジンの変種およびそれらの使用
GB0600928D0 (en) 2006-01-17 2006-02-22 Novacta Biosystems Ltd Improvements relating to lantibiotics
EP3594248B1 (en) 2006-10-27 2021-08-04 Capsugel Belgium NV Hydroxypropyl methyl cellulose hard capsules and process of manufacture
US20110150917A1 (en) 2007-06-12 2011-06-23 The University Of British Columbia Small Cationic Antimicrobial Peptides
GB0714029D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd Lantibiotic-based compounds having antimicrobial activity
GB0714030D0 (en) * 2007-07-18 2007-08-29 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity
MX2011005425A (es) 2008-11-24 2011-09-27 Sentinella Pharmaceuticals Inc Sentinella Derivados de carboxiamida lantibiotica con actividad antibacteriana mejorada.
GB0900599D0 (en) 2009-01-14 2009-02-18 Novacta Biosystems Ltd Treatment
NZ594011A (en) * 2009-01-14 2013-12-20 Novacta Biosystems Ltd Deoxyactagardine derivatives
TWI504610B (zh) 2009-02-04 2015-10-21 Novacta Biosystems Ltd 阿肽加定衍生物、其製備方法及其用途

Also Published As

Publication number Publication date
US20100261638A1 (en) 2010-10-14
AU2008277422A1 (en) 2009-01-22
GB0714029D0 (en) 2007-08-29
CN101796067A (zh) 2010-08-04
IL202620A0 (en) 2010-06-30
CA2693051A1 (en) 2009-01-22
WO2009010765A3 (en) 2009-04-23
NZ581885A (en) 2012-03-30
EA200971101A1 (ru) 2010-08-30
JP2010533696A (ja) 2010-10-28
EA018841B1 (ru) 2013-11-29
US8329644B2 (en) 2012-12-11
WO2009010765A2 (en) 2009-01-22
JP5389023B2 (ja) 2014-01-15
EP2167527A2 (en) 2010-03-31
KR20100044849A (ko) 2010-04-30

Similar Documents

Publication Publication Date Title
BRPI0814555A2 (pt) O uso de compostos à base de lantibiótico com atividade antimicrobiana
BRPI0814034A2 (pt) Uso de compostos à base de lantibiótico tipo-b com atividade antimicrobiana
BRPI0821668A2 (pt) Uso
DK1961744T3 (da) Forbindelse indeholdende basiske grupper samt anvendelse deraf
CR10847A (es) Compuesto heteromonociclico y uso del mismo
BRPI0716327A2 (pt) Composto de fenilpropionamida e uso
BRPI0813457A2 (pt) Composto de organoenxofre contendo halogênio e uso do mesmo
BRPI0808013A2 (pt) Compostos de quinoxalina e uso dos mesmos
DE602004025215D1 (de) Tastsonde
BRPI0813587A2 (pt) Composto, uso do mesmo, e, composição farmacêutica
DE602006003113D1 (de) Aiguille à ponction guidee ultrasoniquement
EP1942232A4 (en) Construct
DE602006020744D1 (de) Fertigspritze
DE502005000300D1 (de) Tastkopf
BRPI0809002A2 (pt) Macrolídeos à base de eritromicina
ATE494533T1 (de) Messfühleranordnung
DK1928464T3 (da) Ny parenteral carbamazepin-formulering
DE112006001562A5 (de) Linearachse
FI20041538L (fi) Goniometri
ITMI20051957A1 (it) Composti e relativo uso per il controllo di fitoparogeni
FI7890U1 (fi) Tukielin
NO20052429D0 (no) Konstrastmidler
DE502006002822D1 (de) Ges
DE112006002683A5 (de) Messuhrhalter
ES1060333Y (es) Puntal telescopico

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]